Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Shire CEO thinks he can beat $500M in postmerger cost savings
Shire CEO thinks he can beat $500M in postmerger cost savings
Shire CEO thinks he can beat $500M in postmerger cost savings
Submitted by
admin
on January 14, 2016 - 10:13am
Source:
Fierce Pharma
News Tags:
Shire
Pharma CEOs
Flemming Ornskov
Baxalta
M&A
Headline:
Shire CEO thinks he can beat $500M in postmerger cost savings
Do Not Allow Advertisers to Use My Personal information
